BIOSHELL C18;2.7UM;25CMX2.1MM;1000A

Code: 582704-u D2-231

Analysis Note

The target analytes include monoclonal antibodies, antibody-drug conjugates, antibody fragments and large proteins with molecular weights up to 500 kDa.

<...


read more

Your Price
£1,050.00 EACH
£1,260.00 inc. VAT

Analysis Note

The target analytes include monoclonal antibodies, antibody-drug conjugates, antibody fragments and large proteins with molecular weights up to 500 kDa.

Application

UHPLC Analysis of Reduced IgG1 on BIOshell IgG 1000 Å C18UHPLC Analysis of Proteins on BIOshell IgG 1000 Å C18, 2.7 µmUHPLC Analysis of Proteins on BIOshell IgG 1000 Å C18, 2.7 µmUHPLC Analysis of IgG2 on BIOshell IgG 1000 Å C4, C18, and Diphenyl, 2.7 µm

General description

BIOshell IgG 1000 Å C18 is a high-speed, high-performance liquid chromatography column based on a new wide-pore (1000 Å) Fused-Core® particle design. The particle provides a thin porous shell of high-purity silica surrounding a solid silica core. This particle design exhibits very high column efficiency due to the shallow diffusion paths in the 0.5 µm thin porous shell and the small overall particle size of 2.7 µm. The sterically protected C18 bonded phase of BIOshell IgG 1000 Å C18 provides a stable, reversed-phase packing that can be used for separating high molecular weight compounds, such as proteins.

Legal Information

BIOshell is a trademark of Sigma-Aldrich Co. LLC

Fused-Core is a registered trademark of Advanced Materials Technology, Inc.

agencysuitable for USP L1
column L × I.D.25 cm × 2.1 mm
extent of labeling1.4% Carbon loading
featureendcapped
materialstainless steel column
matrix active groupC18 (diisobutyloctadecylsilane) bonding phase
matrixFused-Core® particle platform, superficially porous particle
operating pH range1-8
packaging1 ea of
particle size2.7 µm
pore size1000 Å pore size
product lineBIOshell
separation techniquereversed phase
surface area22 m2/g
technique(s)UHPLC-MS: suitable, HPLC: suitable, LC/MS: suitable, UHPLC: suitable
This product has met the following criteria: